Abstract
Introduction: Hemorrhaging occurs in approximately 6%-10% of pts with advanced cancer and in some pts it may be the immediate cause of death. Hyperfibrinolysis (HF) is a part of acute coagulopathy in cancer pts. Thromboelastography (TEG) is able to measure the extent of fibrinolysis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
